期刊文献+

ICU患者侵袭性真菌感染风险评分系统的建立和评价 被引量:7

A scoring system to predict the risk of nosocomial invasive fungal infections in the intensive care unit
下载PDF
导出
摘要 目的了解ICU患者侵袭性真菌感染(IFIs)的危险因素,并建立预测IFIs发生风险的评分系统。方法选择2007年1月至2011年12月在安徽省5家三级甲等医院(ICU)明确诊断为IFIs的患者,共计192例,并选择192例同期住院的非IFIs患者作为对照组。利用单因素分析进行筛选,然后使用多因素Logistic回归分析发现IFIs的独立危险因素并建立评分系统,采用ROC曲线评价该评分系统。结果多因素Logistic回归分析结果显示,IFIs独立的危险因素有:年龄(>65岁),慢性肾功能不全,实体肿瘤,使用广谱抗生素,中心静脉导管,多次入住ICU,APACHE II评分。评分系统ROC曲线下面积为0.856(95%CI,0.811~0.901),应用评分系统在测试样本中进行评估,其预测IFIs与实际相符率为76.6%。结论该评分系统能较准确地预测IFIs的发生,可以为IFIs预警并进行早期干预和治疗提供依据。 Objective To analyze the influencing factors of nosocomial invasive fungal infections(IFIs) in the intensive care unit and to develop and assess the performance of a scoring system to predict the risk of IFIs.Methods A total of 192 IFIs patients and 192 non-IFIs patients as the control group in the ICU of five hospitals were included for the study between January 2007 and December 2011.Variables associated with IFIs were identified by multivariable logistic regression and used to develop a predictive model.Performance of the scoring system was assessed by receiver-operating characteristics(ROC) curve analysis and verified on a test dataset.Results Seven variables were identified as the most important independent risk factors for IFIs and were used to construct a scoring system: age(65 year),solid tumor,chronic renal failure,broad-spectrum antibiotic use,central venous catheter use,multiple-admission in ICU,and Acute Physiology and Chronic Health Evaluation II(APACHE II) score.A scoring system was computed by the logistic equation.A cutoff point of 0.454 provided the greatest sensitivity and specificity.The scoring index had good discriminative power,and the area under the receiver operating characteristic curve was 0.856(95%CI,0.811-0.901).When the scoring system was used in another 128 ICU patients,the total coincidence ratio was 76.6% between predicted and actual condition.Conclusion Our scoring system can give an early and reliable prognosis of IFIs,which can be used as a guide to perform early intervention and treatment in clinical practice.Future validation of this scoring system is necessary.
出处 《安徽医学》 2012年第11期1426-1429,共4页 Anhui Medical Journal
基金 安徽省卫生厅科研基金(项目编号:2008A013)
关键词 侵袭性真菌感染 评分系统 危险因素 ICU Invasive fungal infections Scoring system Risk factors Intensive care unit
  • 相关文献

参考文献11

  • 1Ostrosky - Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med, 2006,34 ( 3 ) : 857 - 863.
  • 2Playford EG, Eggimann P, Calandra T. Antifungals in the ICU. Curr Opin Infect Dis,2008,21 (6) :610 -619.
  • 3邵敏,刘宝,孙耕耘.危重病患者下呼吸道真菌感染的危险因素分析[J].安徽医学,2010,31(5):452-454. 被引量:6
  • 4Thomas JG, Madigan M. A retrospective study to evaluate a computer based model for amplifying, early antifungal inter- vention and microbial detection of patients at risk for funge- mia. Presented at Seventh Annual Focus on Fungal Infec- tion. San Antoni,TX, 1997 : 13 - 15.
  • 5重症患者侵袭性真菌感染诊断与治疗指南(2007)[J].中华内科杂志,2007,46(11):960-966. 被引量:427
  • 6Kett DH, Azoulay E, Echeverria PM, et al. Candida blood- stream infections in intensive care units: analysis of the ex- tended prevalence of infection in intensive care unit study. Crit Care Med,2011,39(4) :665 -670.
  • 7Moran C, Grussemeyer CA, Spalding JR, et al. Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections. Am J Infect Control,2010,38 ( 1 ) :78 - 80.
  • 8Bassetti M, Righi E, Costa A, et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis, 2006,6( 1 ) :21.
  • 9Dimopoulos G, Piagnerelli M, Bert6 J, et al. Post mortem ex- amination in the intensive care unit: still useful? Intensive Care Med ,2004,30( 11 ) :2080 - 2085.
  • 10Muskett H, Shahin J, Eyres G, et al. Risk factors for invasive fungai disease in critically ill aduh patients: a systematic re- view. Crit Care ,2011,15 (6) : R287.

二级参考文献20

  • 1刘伟,李若瑜.抗真菌药物敏感性试验在真菌感染防治中的作用[J].中华检验医学杂志,2005,28(4):349-351. 被引量:30
  • 2黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 3侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:865
  • 4Felmingham D, Gruneberg RN. The Alexander project 1996 -1997: a test susceptibility data from this international study of bacterial pathogens from community - acquired lower respiratory tract infections. J Antimicrob Chemother,2000, 45(2) :191 -203.
  • 5Song JH, Jung SI, Ko KS, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia(an ANSORP study). Antimicrob Chemother,2004,48(6) :2101 -2107.
  • 6Pihlajamaki M, Kataja J, Seppala H, et al. Ribosomal.mutations in Streptococcus pneumoniaeclinical isolates. Antimicrob Agents Chemother, 2002, 46 (3) : 654 - 658.
  • 7Tortorano AM, Caspani L, Rigoni AL, et al. Candidosis in the intensive care unit: a 20 - year survey. J Hosp Infect, 2004, 57(1) : 8 -13.
  • 8Pfaller M A,Diekema D J,Messer S A,et al.Activities of fluconazole and voriconazole against 1 586 recent clinical isolates of Candida species determined by broth microdilution,disk diffusion,and E test methods:report from the ARTEMIS Global Antifungal Susceptibility Program,2001[J].J Clin Microbiol,2003,41(4):1440-1446.
  • 9De Pauw B E,Meis J F.Progress in fighting systemic fungal infections in haematological neoplasia[J].Support Care Cancer,1998,6(1):31-38.
  • 10Eubanks P J,de Virgilio C,Klein S,et al.Candida sepsis in surgical patients[J].Am J Surg,1993,166(6):617-620.

共引文献437

同被引文献53

  • 1王东浩.乳酸清除率评估重度脓毒症患者预后的临床分析[J].中国急救医学,2007,27(1):15-17. 被引量:96
  • 2张隆群,罗盛淑,王小梅.肝移植术后肺部感染的原因分析及对策[J].重庆医科大学学报,2007,32(7):751-753. 被引量:6
  • 3Latham J,Campbell D,Nichols W. Clinical inquiries.How much can exercise raise creatine kinase level-and does it matter[J].{H}Journal of Family Practice,2008,(08):545-547.
  • 4Morandi L,Angelini C,Prelle A. High plasma creatine kinase:review of the literature and proposal for a diagnostic algorithm[J].{H}Neurological Sciences,2006,(05):303-311.
  • 5Caston-Osorio JJ, Rivero A, Torre-Cisneros J.Epidemiology of inva-sive fungal infection[ J].Int J Antimicrob Agents, 2008,32(2):103-109.
  • 6Quindos G. Epidemiology of candidaemia and invasive candidiasis:A changing face[ J]. Rev IberoamMicol,2014,31( I) :42-48.
  • 7Ruping M J,Vehreschild J J, Comely 0 A. Patients at high risk ofinvasive fungal infections: when and how to treat[ J]. Drugs, 2008,68(14) : 1941-1962.
  • 8Larbcharoensub N, Srisuma S, Ngemprasertsri T, et al.. Invasivefungal infection in Ramathibodi Hospital : a ten-yearautopsy review[J].J Med Assoc Thai,2012,90( 12) :2630-2637.
  • 9Sciascia S,Ceberio L,Garcia-Femandez C,et al. Systemic lupus er-ythematosus and infections : clinical importance of conventional andupcoming biomarkers[ J]. Autoimmun Rev,2012,12(2) : 157-163.
  • 10Wei-I Tsai, Chien-Sheng Wu, Ping-Ning Hsu. Invasive fungalinfections in systemic lupus erythematosus : 10-year experience in ateaching hospital in Taiwan [ J ]. Formosan Journal ofRheumatology,2009, (23) :43-51.

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部